sulfasalazine has been researched along with Acropachy, Hereditary in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anders, HJ | 1 |
| Sanden, S | 1 |
| Krüger, K | 1 |
| Dosik, JS | 1 |
2 other studies available for sulfasalazine and Acropachy, Hereditary
| Article | Year |
|---|---|
[Psoriatic onycho-pachydermo- periostitis].
Topics: Arthritis, Psoriatic; Combined Modality Therapy; Diagnosis, Differential; Humans; Male; Middle Aged; | 2002 |
Psoriatic onycho-pachydermo-periostitis.
Topics: Biopsy; Face; Humans; Male; Methotrexate; Middle Aged; Osteoarthropathy, Primary Hypertrophic; Penis | 2001 |